Copper ions are needed in several steps of cancer progression. However, the underlying mechanisms, and involved copper-binding proteins, are mainly elusive. Since most copper ions in the body (in and outside cells) are protein-bound, it is important to investigate what copper-binding proteins participate and, for these, how they are loaded with copper by copper transport proteins. Mechanistic information for how some copper-binding proteins, such as extracellular lysyl oxidase (LOX), play roles in cancer have been elucidated but there is still much to learn from a biophysical molecular viewpoint. Here we provide a summary of copper-binding proteins and discuss ones reported to have roles in cancer. We specifically focus on how copper-binding proteins such as mediator of cell motility 1 (MEMO1), LOX, LOX-like proteins, and secreted protein acidic and rich in cysteine (SPARC) modulate breast cancer from molecular and clinical aspects. Because of the importance of copper for invasion/migration processes, which are key components of cancer metastasis, further insights into the actions of copper-binding proteins may provide new targets to combat cancer.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oSkEnX
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Liver ischemia reperfusion injury (IRI) is inevitable during transplantation and resection and is characterized by hepatocellular injury. Th...
-
IJERPH, Vol. 15, Pages 162: Examining Public Perceptions about Lead in School Drinking Water: A Mixed-Methods Analysis of Twitter Response t...
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
Radioterapia oncologica, la Cattolica protagonista al Congresso Europeo insalutenews ... l'utilizzo della radioterapia stereotass...
-
Abstract Background Individualized medication reviews may improve our understanding of the distribution of CYP2C19 polymorphisms in ethn...
-
Abstract Background and Objective Sonidegib is a potent, selective and orally bioavailable inhibitor of the Hedgehog signaling pathway, ...
-
Aim: This study was designed to evaluate the clinical characteristics and prognosis of elderly small cell lung cancer (SCLC) patients compli...
-
Abstract: We present a case of cutaneous apocrine carcinoma arising in the axilla of a 71-year-old man. The tumor had a significant componen...
-
Publication date: Available online 10 May 2017 Source: Journal of Dairy Science Author(s): N. Urrutia, K.J. Harvatine During biohydrogen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου